{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:57:54Z","timestamp":1791705474305,"version":"4.3.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.jcv.2004.07.005","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T22:45:53Z","timestamp":1095201953000},"page":"47-52","source":"Crossref","is-referenced-by-count":32,"title":["Standardization of a neutralizing anti-vaccinia antibodies titration method: an essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluation"],"prefix":"10.1016","volume":"32","author":[{"given":"Isabelle","family":"Leparc-Goffart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Garin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Tissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Crance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2004.07.005_bib1","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"10.1016\/j.jcv.2004.07.005_bib2","first-page":"1","article-title":"Smallpox vaccination and adverse reactions. Guidance for clinicians","volume":"52","author":"Cono","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jcv.2004.07.005_bib3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1086\/378518","article-title":"Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques","volume":"188","author":"Edghill-Smith","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2004.07.005_bib4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/infdis\/161.3.446","article-title":"The persistence of neutralizing antibodies after revaccination against smallpox","volume":"161","author":"El-Ad","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2004.07.005_bib5","unstructured":"European Pharmacopoeia. Statistical analysis of results of biological assays and tests, version 4; 2003 (chapter 5.3)."},{"key":"10.1016\/j.jcv.2004.07.005_bib6","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa013431","article-title":"Dose-related effects of smallpox vaccine","volume":"346","author":"Frey","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcv.2004.07.005_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1542\/peds.55.3.342","article-title":"Smallpox vaccination reactions, prophylaxis, and therapy of complications","volume":"55","author":"Goldstein","year":"1975","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcv.2004.07.005_bib8","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jcv.2004.07.005_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0092-1157(87)80013-6","article-title":"The effect of the virus-serum incubation period upon vaccinia virus serum neutralization titers","volume":"15","author":"Katz","year":"1987","journal-title":"J Biol Stand"},{"key":"10.1016\/j.jcv.2004.07.005_bib10","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1128\/JCM.41.8.3687-3689.2003","article-title":"New generation of cell culture assay for smallpox vaccine potency","volume":"41","author":"Leparc-Goffart","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2004.07.005_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2807\/esm.06.11.00385-en","article-title":"The use of smallpox virus as a biological weapon: the vaccination situation in France","volume":"6","author":"L\u00e9vy-Bruhl","year":"2001","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jcv.2004.07.005_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/513968","article-title":"Immunologic responses to vaccinia vaccines administered by different parenteral routes","volume":"175","author":"McClain","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2004.07.005_bib13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0140-6736(73)92215-0","article-title":"Experience of anti-vaccinia immunoglobulin in the United Kingdom","volume":"1","author":"Sharp","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2004.07.005_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0264-410X(98)00197-2","article-title":"Kinetics of formation of neutralizing antibodies against vaccinia virus following re-vaccination","volume":"17","author":"Stienlauf","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2004.07.005_bib15","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nm916","article-title":"Clonal vaccinia virus grown in cell culture as a new smallpox vaccine","volume":"9","author":"Weltzin","year":"2003","journal-title":"Nat Med"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653204001970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653204001970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T09:36:01Z","timestamp":1682760961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653204001970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S1386653204001970"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2004.07.005","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}